Decision Science Advisors Raises Series A From Jefferies to Expand Applied AI and Data Advisory for Private Equity

Precision doesn’t raise its voice. It sharpens it. And every so often, a company shows up that understands the difference between sounding smart and actually moving the room. Decision Science Advisors is moving the room, quietly, deliberately, and right on time.

Decision Science Advisors, founded in 2020, by Beth Pollack, just locked in a Series A backed by Jefferies Financial Group Inc. No vanity metrics. No disclosed number to flex in headlines, amount remains unconfirmed. Just capital with intent. And if you’ve been around this game long enough, you know that when Jefferies leans in, it’s not for decoration. It’s because something under the hood is already humming.

Beth Pollack didn’t build Decision Science Advisors to theorize about AI. She built it because most firms talk strategy like it’s a TED Talk and execute like it’s their first day on the job. Decision Science Advisors sits right in that gap, where ideas either turn into operating leverage or quietly die in a slide deck. Applied AI, data strategy, real deployment across private equity portfolios. Not someday. Now.

The market is split right now. One side is still workshopping what AI might eventually mean for private equity. The other side is already embedding it into how value is created, measured, and realized. Decision Science Advisors operates with the second mindset. From diligence to post-close value creation, they’re threading AI into the actual mechanics of how money is made. Not just analyzed. Made.

Jefferies doesn’t just bring capital here. They bring proximity to deal flow, to operators, to pressure. That kind of partnership tends to accelerate things that are already working and expose anything that isn’t. So this isn’t about adding a logo to the investor slide. It’s about tightening the feedback loop between strategy and outcome.

There’s also a subtle play in the name itself. Decision Science Advisors. Not AI consultants. Not data gurus. Decision. Science. Advisors. Three words that quietly call out the real problem most firms have. They don’t lack data. They lack decisions that actually move the needle. And science implies repeatability, not guesswork dressed up as insight.

What stands out isn’t just the funding. It’s the restraint. No inflated claims. No over-engineered narrative. Just a firm that understands if you can consistently turn data into decisions, and decisions into value, you don’t need to be the loudest voice in the room. The results carry the conversation.